EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease

Masanobu Ishii, Koichiro Fujisue, Koichi Kaikita, Kenshi Yamanaga, Shinsuke Hanatani, Yasushi Matsuzawa, Mitsutoshi Miura, Takashi Kudo, Hideki Shimomura, Masafumi Takae, Yuichiro Shirahama, Nobuyasu Yamamoto und 13 weitere

Journal of Atherosclerosis and Thrombosis · 2026

DOI: 10.5551/jat.65984 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2026. Verfasst von Masanobu Ishii und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University. Hauptthemen laut MEDLINE: Coronary Artery Disease, Fibrinogen, Butyrates, Thrombosis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseFibrinogenButyratesThrombosisBenzoxazolesHypertriglyceridemiaHumansFemaleMaleMiddle AgedAgedFollow-Up Studies

Stichwörter der Autor:innen

Coronary artery diseaseFibrinogenPemafibrateSPPARMαThrombogenicity

Substanzen

FibrinogenButyrates(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acidBenzoxazoles

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.
  • Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University.
  • Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki.
  • Department of Cardiovascular Medicine, Kumamoto Central Hospital.
  • Department of Cardiovascular Medicine, Fukuoka Tokushukai Medical Center.
  • Department of Cardiovascular Medicine, Miyazaki Prefectural Nobeoka Hospital.

Zitieren

APA

Ishii, M., Fujisue, K., Kaikita, K., Yamanaga, K., Hanatani, S., Matsuzawa, Y., Miura, M., Kudo, T., Shimomura, H., Takae, M., Shirahama, Y., Yamamoto, N., Ito, T., Tsunoda, R., Horio, E., Sakamoto, T., Rokutanda, T., Morihisa, K., Noda, K., …, & PEMA-TAS Investigators (2026). The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65984

Vancouver

Ishii M, Fujisue K, Kaikita K, Yamanaga K, Hanatani S, Matsuzawa Y, et al. The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. 2026. doi:10.5551/jat.65984

BibTeX
@article{Ishii2026,
  author = {Ishii, Masanobu and Fujisue, Koichiro and Kaikita, Koichi and Yamanaga, Kenshi and Hanatani, Shinsuke and Matsuzawa, Yasushi and Miura, Mitsutoshi and Kudo, Takashi and Shimomura, Hideki and Takae, Masafumi and Shirahama, Yuichiro and Yamamoto, Nobuyasu and Ito, Teruhiko and Tsunoda, Ryusuke and Horio, Eiji and Sakamoto, Tomohiro and Rokutanda, Taku and Morihisa, Kenji and Noda, Katsuo and Tanaka, Hiroki and Matsuura, Yunosuke and Yamamoto, Eiichiro and Izumiya, Yasuhiro and Tsujita, Kenichi and PEMA-TAS Investigators, PEMA-TAS Investigators},
  title = {The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  doi = {10.5551/jat.65984}
}
Kostenlos starten →